1. Home
  2. HUMA vs SRG Comparison

HUMA vs SRG Comparison

Compare HUMA & SRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • SRG
  • Stock Information
  • Founded
  • HUMA 2004
  • SRG 2014
  • Country
  • HUMA United States
  • SRG United States
  • Employees
  • HUMA N/A
  • SRG N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • SRG Real Estate Investment Trusts
  • Sector
  • HUMA Health Care
  • SRG Real Estate
  • Exchange
  • HUMA Nasdaq
  • SRG Nasdaq
  • Market Cap
  • HUMA 250.2M
  • SRG 206.7M
  • IPO Year
  • HUMA N/A
  • SRG 2015
  • Fundamental
  • Price
  • HUMA $1.70
  • SRG $4.14
  • Analyst Decision
  • HUMA Strong Buy
  • SRG
  • Analyst Count
  • HUMA 8
  • SRG 0
  • Target Price
  • HUMA $10.88
  • SRG N/A
  • AVG Volume (30 Days)
  • HUMA 2.9M
  • SRG 140.6K
  • Earning Date
  • HUMA 11-07-2025
  • SRG 11-11-2025
  • Dividend Yield
  • HUMA N/A
  • SRG N/A
  • EPS Growth
  • HUMA N/A
  • SRG N/A
  • EPS
  • HUMA N/A
  • SRG N/A
  • Revenue
  • HUMA $818,000.00
  • SRG $15,346,000.00
  • Revenue This Year
  • HUMA N/A
  • SRG N/A
  • Revenue Next Year
  • HUMA $1,619.38
  • SRG N/A
  • P/E Ratio
  • HUMA N/A
  • SRG N/A
  • Revenue Growth
  • HUMA N/A
  • SRG N/A
  • 52 Week Low
  • HUMA $1.15
  • SRG $2.43
  • 52 Week High
  • HUMA $6.77
  • SRG $4.77
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 52.69
  • SRG 63.59
  • Support Level
  • HUMA $1.45
  • SRG $4.01
  • Resistance Level
  • HUMA $1.53
  • SRG $4.30
  • Average True Range (ATR)
  • HUMA 0.10
  • SRG 0.18
  • MACD
  • HUMA 0.05
  • SRG -0.00
  • Stochastic Oscillator
  • HUMA 65.31
  • SRG 55.74

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About SRG Seritage Growth Properties

Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.

Share on Social Networks: